ATE88507T1 - Diagnostische probe zum nachweis von praedisposition fuer diabetes typ 1. - Google Patents

Diagnostische probe zum nachweis von praedisposition fuer diabetes typ 1.

Info

Publication number
ATE88507T1
ATE88507T1 AT88310163T AT88310163T ATE88507T1 AT E88507 T1 ATE88507 T1 AT E88507T1 AT 88310163 T AT88310163 T AT 88310163T AT 88310163 T AT88310163 T AT 88310163T AT E88507 T1 ATE88507 T1 AT E88507T1
Authority
AT
Austria
Prior art keywords
diabetes
type
diagnostic sample
probe
thymine
Prior art date
Application number
AT88310163T
Other languages
English (en)
Inventor
Gerald T Nepom
Original Assignee
Virginia Mason Res Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Mason Res Center filed Critical Virginia Mason Res Center
Application granted granted Critical
Publication of ATE88507T1 publication Critical patent/ATE88507T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88310163T 1987-10-29 1988-10-28 Diagnostische probe zum nachweis von praedisposition fuer diabetes typ 1. ATE88507T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/114,559 US5039606A (en) 1987-10-29 1987-10-29 Diagnostic probe for diabetes type I predisposition
EP88310163A EP0314500B1 (de) 1987-10-29 1988-10-28 Diagnostische Probe zum Nachweis von Prädisposition für Diabetes Typ 1

Publications (1)

Publication Number Publication Date
ATE88507T1 true ATE88507T1 (de) 1993-05-15

Family

ID=22355999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88310163T ATE88507T1 (de) 1987-10-29 1988-10-28 Diagnostische probe zum nachweis von praedisposition fuer diabetes typ 1.

Country Status (7)

Country Link
US (1) US5039606A (de)
EP (1) EP0314500B1 (de)
JP (1) JP2975023B2 (de)
AT (1) ATE88507T1 (de)
AU (1) AU612418B2 (de)
CA (1) CA1299506C (de)
DE (1) DE3880434T2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194561B1 (en) 1986-03-13 2001-02-27 Roche Molecular Systems, Inc. Characterization and detection of sequences associated with autoimmune diseases
CA1284931C (en) * 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5604099A (en) * 1986-03-13 1997-02-18 Hoffmann-La Roche Inc. Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5079343A (en) * 1990-01-05 1992-01-07 Dana-Farber Cancer Institute, Inc. Intracellular antigen found in subpopulation of cd8+ t lymphocytes and monoclonal antibody reactive with same
US5340935A (en) * 1990-01-05 1994-08-23 Dana-Farber Cancer Institute, Inc. DNAS encoding proteins active in lymphocyte-medicated cytotoxicity
DK0515660T3 (da) * 1990-12-21 1997-07-28 Hoffmann La Roche HLA-DQbeta-DNA-typebestemmelse
DE4114365A1 (de) * 1991-05-02 1992-11-05 Max Planck Gesellschaft Verfahren zur diagnose von nicht-insulin-abhaengigem diabetes mellitus
DE4224738A1 (de) * 1992-07-27 1994-02-03 Engler Blum Gabriele Verfahren zur Analyse molekularer organischer Strukturen
DE9402109U1 (de) * 1994-02-09 1994-03-31 Maartens Kleinmetaal B.V., Haarlem Rotationsschneidwerkzeug
US5763591A (en) * 1996-03-25 1998-06-09 Cedars-Sinai Medical Center Polynucleic acid sequences that are functionally associated with the development of autoimmune disease
FR2749308B1 (fr) * 1996-06-03 1998-07-24 Bio Merieux Sondes nucleotidiques et procede pour determiner le typage hla dqb1
GB9621129D0 (en) 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6852493B2 (en) 1999-05-14 2005-02-08 Iris Biotechnologies, Inc. Magnetic field enhanced hybridization of target molecules to immobilized probes
WO2000073506A1 (en) * 1999-05-27 2000-12-07 Iris Biotechnologies, Inc. Method for increasing the hybridization rate of nucleic acids
WO2008016988A1 (en) * 2006-08-01 2008-02-07 Gen-Probe Incorporated Methods of nonspecific target capture of nucleic acids
CA2718986A1 (en) * 2008-04-09 2009-10-15 Pacific Northwest Research Institute Methods for screening for genetic predisposition to type i diabetes
WO2011083477A1 (en) * 2010-01-10 2011-07-14 New Diabetic Solutions Immuno-tolerance formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2614853B2 (ja) * 1985-06-14 1997-05-28 ジェネティック システムズ コーポレイション 増加した危機の糖尿病に関連する対立遺伝子を同定するための方法
CA1284931C (en) * 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
WO1988002999A1 (en) * 1986-10-22 1988-05-05 Prize Frize, Inc. Apparatus and method for preparing fried potato products

Also Published As

Publication number Publication date
EP0314500B1 (de) 1993-04-21
AU2410988A (en) 1989-05-04
JPH02500A (ja) 1990-01-05
DE3880434D1 (de) 1993-05-27
DE3880434T2 (de) 1993-09-02
JP2975023B2 (ja) 1999-11-10
US5039606A (en) 1991-08-13
AU612418B2 (en) 1991-07-11
EP0314500A2 (de) 1989-05-03
EP0314500A3 (en) 1989-07-26
CA1299506C (en) 1992-04-28

Similar Documents

Publication Publication Date Title
DE3880434D1 (de) Diagnostische probe zum nachweis von praedisposition fuer diabetes typ 1.
EP0138357A3 (en) Labeled dna
Kunkel et al. Depurination-induced infidelity of DNA synthesis with purified DNA replication proteins in vitro
ATE486965T1 (de) Verfahren zur typisierung und zum nachweis von hbv
ATE233816T1 (de) Gereinigtes thermostabiles nukleinsäure- polymeraseenzym aus thermotoga maritima
KR930010192A (ko) 에이치엘에이(hla) 제i형 디엠에이(dna) 타이핑 방법 및 시약
ES2217280T3 (es) Metodo para la deteccion del espectro de resistencia antibiotica de especies de microbacterias.
DK0517796T3 (da) Oligonukleotid-analoger
CA2381098A1 (en) Polymerase extension at 3' terminus of pna-dna chimera
DK0800587T3 (da) Komparativ hybridisering af nukleinsyrerækker
DE69834056D1 (de) De novo oder "universaler" sequenzierungs-array
WO2000041549A2 (en) Binary probe and clamp composition and methods for target hybridization detection
NO933136L (no) Bestemmelse av nukleinsyrer ved polymerasekstensjon av oligonukleotider ved anvendelse av terminatorblandinger
ATE211481T1 (de) C-nukleosid-derivate und deren verwendung in der detektion von nukleinsäuren
DE69215169D1 (de) Nachweis von komplementären Nukleotid-Sequenzen
Jamieson et al. Deoxyribonucleoside triphosphate pools in herpes simplex type 1 infected cells
US6063571A (en) Process for amplifying nucleic acids using DNA/PNA primers
SE9101585D0 (sv) Substrate for polymerase activity determination
WO1996011937A1 (en) Porphyrin labeling of polynucleotides
DE68909445D1 (de) Methode zur bestimmung genetischer sequenzen und testsatz hierfuer.
ES2206551T3 (es) Deteccion de enterobacterias.
EP0453290A3 (en) Nucleic acid probes for the detection of giardia lamblia and methods of detection
DE60024464D1 (de) Hohe dichte markierung von dns mit modifizierte oder chromophore tragende nukleotide und benutzte dns polymerasen
US6413718B1 (en) Method for sequencing of nucleic acid polymers
US5776673A (en) Treatment and detection of tuberculosis, leprosy, and related diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties